LeonaBio Inc.
LONA | NASDAQ
$5.17
+$0.23 (+4.66%)
Nov 2, 2026, 10:09 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 68.09M | n/a | n/a | n/a | 479K | 2M |
Gross Profit | -68.09M | n/a | n/a | n/a | -479K | -2M |
Operating Income | -102.27M | -100.9M | -125.47M | -104.02M | -64.02M | -20M |
Interest Income | n/a | 3.96M | 7.64M | 3.22M | 337K | 124K |
Pretax Income | -105.61M | -96.94M | -117.67M | -95.64M | -54.85M | -19.96M |
Net Income | -105.61M | -96.94M | -117.67M | -95.64M | -54.85M | -19.96M |
Selling & General & Admin | 16.68M | 26.09M | 33.3M | 32.55M | 21.23M | 6.71M |
Research & Development | 17.5M | 70.68M | 93.79M | 61.46M | 42.79M | 13.29M |
Other Expenses | n/a | 4.13M | -1.63M | 10M | -479K | -2M |
Operating Expenses | 34.18M | 100.9M | 125.47M | 104.02M | 63.54M | 18M |
Interest Expense | n/a | n/a | n/a | 24.32M | 3K | 367K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 102.27M | 100.9M | 125.47M | 104.02M | 64.02M | 20M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.28M | 3.85M | 3.8M | 3.77M | 3.69M | 3.25M |
Shares Outstanding (Diluted) | 4.28M | 3.85M | 3.8M | 3.77M | 3.69M | 3.25M |
EPS (Basic) | -24.70 | -25.20 | -30.90 | -25.30 | -14.90 | -6.10 |
EPS (Diluted) | -24.70 | -25.20 | -30.90 | -25.30 | -14.90 | -6.10 |
EBITDA | -33.21M | -95.81M | -125.97M | -88.01M | -54.37M | -19.59M |
EBIT | -34.18M | -96.78M | -126.94M | -88.86M | -54.85M | -19.59M |
Depreciation & Amortization | 972K | 970K | 969K | 845K | 479K | 2K |
Add to Watchlist
Select watchlists to add or remove LONA